Jeffrey Conroy
Vorstandsvorsitzender bei Embody, Inc.
Profil
Jeffrey Conroy is the Chairman & Chief Executive Officer and founder of Embody, Inc. which is founded in 2014.
He is currently an Independent Director at Cingulate Therapeutics LLC, Virginia Biosciences Health Research Corp., and Cingulate Works, Inc. He was formerly the Chairman of Virginia Biotechnology Association from 2014 to 2017.
He was also a Managing Director at Windward Investments LLC from 2012 to 2019 and Adjuvant Partners LLC from 2000 to 2012.
Additionally, he was the Head-Corporate Development at Específicos Stendhal SA de CV from 2012 to 2019.
He holds an undergraduate degree from Providence College.
Aktive Positionen von Jeffrey Conroy
| Unternehmen | Position | Beginn |
|---|---|---|
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Direktor/Vorstandsmitglied | 31.05.2018 |
Embody, Inc.
 Embody, Inc. Medical SpecialtiesHealth Technology Embody, Inc. designs, develops, and distributes implantable medical devices. The company was founded by Jeff Conroy and Michael Francis and is headquartered in Norfolk, VA. | Vorstandsvorsitzender | 01.07.2015 |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Direktor/Vorstandsmitglied | 01.05.2018 |
| Virginia Biosciences Health Research Corp. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jeffrey Conroy
| Unternehmen | Position | Ende |
|---|---|---|
| CINGULATE INC. | Direktor/Vorstandsmitglied | 05.01.2023 |
| ODYSSEY HEALTH, INC. | Direktor/Vorstandsmitglied | 04.01.2023 |
Windward Investments LLC
 Windward Investments LLC Financial ConglomeratesFinance Windward Investments LLC provides investment services. The company was founded in 2001 and is headquartered in Salt Lake City, UT. | Corporate Officer/Principal | 01.12.2019 |
| Específicos Stendhal SA de CV | Corporate Officer/Principal | 01.01.2019 |
Virginia Biotechnology Association
 Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Vorsitzender | 30.08.2017 |
Ausbildung von Jeffrey Conroy
| Providence College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ODYSSEY HEALTH, INC. | Health Technology |
| CINGULATE INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Virginia Biotechnology Association
Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Commercial Services |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Embody, Inc.
Embody, Inc. Medical SpecialtiesHealth Technology Embody, Inc. designs, develops, and distributes implantable medical devices. The company was founded by Jeff Conroy and Michael Francis and is headquartered in Norfolk, VA. | Health Technology |
Windward Investments LLC
Windward Investments LLC Financial ConglomeratesFinance Windward Investments LLC provides investment services. The company was founded in 2001 and is headquartered in Salt Lake City, UT. | Finance |
| Específicos Stendhal SA de CV | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
| Adjuvant Partners LLC | |
| Virginia Biosciences Health Research Corp. |
